105 filings
Page 3 of 6
8-K
akcv4fwz
30 Mar 23
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
4:10pm
8-K
3owsd0
10 Mar 23
Regulation FD Disclosure
2:32pm
8-K
3qv imhh7pwefugrlcv
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
yj247qnr7sy
9 Nov 22
Absci Reports Third Quarter 2022 Financial Results
9:18am
8-K
qe1ne 96ehg7f6hu8
2 Nov 22
Absci Welcomes Meta Senior Executive to Board of Directors
4:06pm
8-K
iv2vpmerzdlkkxvv4
4 Oct 22
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
4:09pm
8-K
xec8t
20 Sep 22
Departure of Directors or Certain Officers
5:14pm
EFFECT
enwforu48hksyr
6 Sep 22
Notice of effectiveness
12:15am
CORRESP
tniyja3tgta hqdf
31 Aug 22
Correspondence with SEC
12:00am
UPLOAD
eucte5a 0ixuy6k
26 Aug 22
Letter from SEC
12:00am
S-3
lrqb7m9u 60r7v
24 Aug 22
Shelf registration
4:07pm
8-K
7x09wsb21lmt2px2l
11 Aug 22
Absci Reports Second Quarter 2022 Financial Results and Business Update
8:33am
8-K
mgmfpdh smskd0sxt
14 Jul 22
Departure of Directors or Certain Officers
5:13pm
8-K
51gaprw4pwen1d4xfj
10 Jun 22
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
mx6llet537
11 May 22
Absci Reports First Quarter 2022 Financial and Operating Results
8:15am
DEFA14A
uv9 kx6749
26 Apr 22
Additional proxy soliciting materials
4:41pm